Span America Medical Systems (SPAN) 10-K 23 Dec 16 2016 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Oct. 01, 2016	Dec. 21, 2016	Apr. 02, 2016
Document Information [Line Items]
Entity Registrant Name	SPAN AMERICA MEDICAL SYSTEMS INC
Entity Central Index Key	718,924
Trading Symbol	span
Current Fiscal Year End Date	--10-01
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		2,755,625
Entity Public Float			$ 43,493,647
Document Type	10-K
Document Period End Date	Oct. 1, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	FY
Amendment Flag	false

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($)		12 Months Ended
		Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Net sales		$ 67,627,170	$ 64,314,996	$ 55,857,375
Cost of goods sold		45,345,994	42,679,013	37,067,737
Gross profit		22,281,176	21,635,983	18,789,638
Selling and marketing expenses		10,504,813	10,789,150	10,088,400
Research and development expenses		1,134,547	1,137,334	1,071,583
General and administrative expenses		4,559,552	4,452,047	4,019,075
		16,198,912	16,378,531	15,179,058
Operating income		6,082,264	5,257,452	3,610,580
Non-operating income (expense):
Foreign currency gain		4,508	401,000	29,868
Interest expense		(5,144)	(6,285)	(12,639)
Other		(7,297)	13,231	958
Net non-operating (expense) income		(7,933)	407,946	18,187
Income before income taxes		6,074,331	5,665,398	3,628,767
Provision for income taxes - Note 13		1,827,000	1,672,000	1,038,000
Net income		4,247,331	3,993,398	2,590,767
Other comprehensive income (loss), after tax:
Foreign currency translation gain (loss)		44,562	(1,539,111)	(794,177)
Comprehensive income		$ 4,291,893	$ 2,454,287	$ 1,796,590
Net income per share:
Basic (in dollars per share)		$ 1.55	$ 1.34	$ 0.88
Diluted (in dollars per share)		1.54	1.33	0.87
Cash dividends, per share (in dollars per share)	[1]	$ 0.64	$ 1.61	$ 0.57
Weighted average shares outstanding:
Basic (in shares)		2,734,862	2,978,107	2,948,992
Diluted (in shares)		2,758,119	3,006,082	2,993,333
[1]	Dividends per share for fiscal year 2015 include a special dividend of $1.00 per share paid on January 7, 2015.

Consolidated Statements of Com3

Consolidated Statements of Comprehensive Income (Parentheticals) - $ / shares		12 Months Ended
		Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Cash dividends, per share (in dollars per share)	[1]	$ 0.64	$ 1.61	$ 0.57
Retained Earnings [Member]
Cash dividends, per share (in dollars per share)		$ 0.64	1.61	$ 0.57
Retained Earnings [Member] | Special Dividend [Member]
Cash dividends, per share (in dollars per share)			$ 1
[1]	Dividends per share for fiscal year 2015 include a special dividend of $1.00 per share paid on January 7, 2015.

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Oct. 01, 2016	Oct. 03, 2015
Current assets:
Cash and cash equivalents	$ 3,752,945	$ 1,224,026
Accounts receivable, net of allowances of $140,000 (2016) and $148,000 (2015)	8,079,500	7,813,773
Inventories - Note 3	7,437,442	8,746,039
Deferred income taxes - Note 13	459,159	351,452
Prepaid expenses	879,108	411,528
Total current assets	20,608,154	18,546,818
Property and equipment, net	4,116,070	4,536,104
Goodwill	3,937,676	3,930,282
Intangibles, net	1,989,899	2,214,762
Other assets - Note 7	2,909,740	2,953,656
	33,561,539	32,181,622
Current liabilities:
Accounts payable	2,410,376	4,035,333
Accrued and sundry liabilities - Note 8	3,583,457	3,120,111
Total current liabilities	5,993,833	7,155,444
Deferred income taxes - Note 13	266,715	348,479
Deferred compensation - Note 11	289,394	375,939
Total long-term liabilities	556,109	724,418
Total liabilities	6,549,942	7,879,862
Commitments and contingencies - Notes 19 and 20
Common stock, no par value, 20,000,000 shares authorized; issued and outstanding shares 2,755,625 (2016) and 2,737,468 (2015)	373,803
Additional paid-in capital	6,025
Retained earnings	29,133,746	26,848,299
Accumulated other comprehensive loss	(2,501,977)	(2,546,539)
Total shareholders' equity	27,011,597	24,301,760
	$ 33,561,539	$ 32,181,622

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parentheticals) - USD ($) $ / shares in Thousands	Oct. 01, 2016	Oct. 03, 2015
Allowance for doubtful accounts	$ 140,000	$ 148,000
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, authorized (in shares)	20,000,000	20,000,000
Common stock, issued (in shares)	2,755,625	2,737,468
Common stock, outstanding (in shares)	2,755,625	2,737,468

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($)	12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
OPERATING ACTIVITIES:
Net income	$ 4,247,331	$ 3,993,398	$ 2,590,767
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	854,940	865,003	864,356
Amortization	325,092	356,775	424,169
Provision for losses on accounts receivable	(9,007)	38,776	128,925
Provision for deferred income taxes	(182,934)	123,435	50,703
Loss (Gain) on sale and disposal of property and equipment	7,704	(13,591)	(73)
Loss on disposal of other assets	3,863
Increase in cash value of life insurance	(154,273)	(49,528)	(174,943)
Deferred compensation	(86,545)	(81,517)	(76,783)
Stock compensation expense		9,041	26,637
Changes in operating assets and liabilities:
Accounts receivable	(247,145)	(2,255,207)	1,692,566
Inventories	1,321,441	(1,703,567)	(1,106,616)
Prepaid expenses and other assets	(97,928)	199,486	164,708
Accounts payable and accrued and sundry liabilities	(1,156,563)	2,779,176	(927,407)
Net cash provided by operating activities	4,825,976	4,261,680	3,657,009
INVESTING ACTIVITIES:
Purchases of property and equipment	(439,693)	(654,865)	(670,845)
Proceeds from sale of property and equipment		47,745	914
Payments for other assets	(99,074)	(82,280)	(80,593)
Net cash used for investing activities	(538,767)	(689,400)	(750,524)
FINANCING ACTIVITIES:
Dividends paid	(1,752,004)	(4,780,572)	(1,683,011)
Proceeds of long-term debt	2,900,000
Repayment of long-term debt	(2,900,000)
Purchase and retirement of common stock	(209,880)	(4,437,251)
Proceeds from exercise of options for common stock	204,423	180,708	273,397
Net cash used for financing activities	(1,757,461)	(9,037,115)	(1,409,614)
Effect of exchange rates on cash	(829)	(177,070)	(55,461)
Increase (Decrease) in cash and cash equivalents	2,528,919	(5,641,905)	1,441,410
Cash and cash equivalents at beginning of year	1,224,026	6,865,931	5,424,521
Cash and cash equivalents at end of year	$ 3,752,945	$ 1,224,026	$ 6,865,931

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity - USD ($)		Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	AOCI Attributable to Parent [Member]	Total
Balance (in shares) at Sep. 28, 2013		2,927,416
Balance at Sep. 28, 2013		$ 2,626,526	$ 872,494	$ 26,828,012	$ (213,251)	$ 30,113,781
Net income				2,590,767		2,590,767
Foreign currency translation gain (loss)					(794,177)	(794,177)
Common stock issued to Directors (in shares)		8,500
Common stock issued to Directors		$ 164,735				$ 164,735
Common stock issued on exercise of stock options (in shares)		26,091				26,091
Common stock issued on exercise of stock options		$ 273,397				$ 273,397
Stock option compensation expense			26,637			26,637
Tax benefits for stock options exercised			7,703			7,703
Cash dividends paid or declared				(1,683,011)		(1,683,011)
Balance (in shares) at Sep. 27, 2014		2,962,007
Balance at Sep. 27, 2014		$ 3,064,658	906,834	27,735,768	(1,007,428)	30,699,832
Net income				3,993,398		3,993,398
Foreign currency translation gain (loss)					(1,539,111)	(1,539,111)
Common stock issued to Directors (in shares)		9,500
Common stock issued to Directors		$ 175,715				$ 175,715
Common stock issued on exercise of stock options (in shares)		19,685				19,685
Common stock issued on exercise of stock options		$ 180,708				$ 180,708
Stock option compensation expense			9,041			9,041
Cash dividends paid or declared	[1]			(4,780,572)		$ (4,780,572)
Balance (in shares) at Oct. 03, 2015		2,737,468				2,737,468
Balance at Oct. 03, 2015				26,848,299	(2,546,539)	$ 24,301,760
Stock repurchases (in shares)		(253,724)
Stock repurchases		$ (3,421,081)	(915,875)	(100,295)		(4,437,251)
Net income				4,247,331		4,247,331
Foreign currency translation gain (loss)					44,562	44,562
Common stock issued to Directors (in shares)		9,000
Common stock issued to Directors		$ 169,380				$ 169,380
Common stock issued on exercise of stock options (in shares)		21,157				21,157
Common stock issued on exercise of stock options		$ 204,423				$ 204,423
Tax benefits for stock options exercised			6,025			6,025
Cash dividends paid or declared				(1,752,004)		$ (1,752,004)
Balance (in shares) at Oct. 01, 2016		2,755,625				2,755,625
Balance at Oct. 01, 2016		$ 373,803	6,025	29,133,746	(2,501,977)	$ 27,011,597
Stock repurchases (in shares)		(12,000)
Stock repurchases				$ (209,880)		$ (209,880)
[1]	Dividends per share for fiscal year 2015 include a special dividend of $1.00 per share paid on January 7, 2015.

Consolidated Statements of Cha8

Consolidated Statements of Changes in Shareholders' Equity (Parentheticals) - $ / shares		12 Months Ended
		Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Retained Earnings [Member] | Special Dividend [Member]
Cash dividends, per share (in dollars per share)			$ 1
Retained Earnings [Member]
Cash dividends, per share (in dollars per share)		$ 0.64	1.61	$ 0.57
Cash dividends, per share (in dollars per share)	[1]	$ 0.64	$ 1.61	$ 0.57
[1]	Dividends per share for fiscal year 2015 include a special dividend of $1.00 per share paid on January 7, 2015.

Note 1 - Significant Accounting

Note 1 - Significant Accounting Policies	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Significant Accounting Policies [Text Block]	1. Description of Business Span - America Medical Systems, Inc. (the “Company,” “we,” or “Span - America”), located in Greenville, SC, manufactures and distributes therapeutic support surfaces, mattress overlays, patient positioners, seating cushions, skin care products and fall prevention products for the medical market and pillows, mattress pads and various foam products for the custom products market throughout the United States and Canada. Our wholly - owned subsidiary, Span Medical Products Canada Inc. (“Span - Canada”), located in Beamsville, Ontario, Canada, manufactures and sells medical bed frames and distributes related in - room furnishing products, including bedside furniture, chairs, tables and over - bed tables for use in the long - term care market. We are operating Span - Canada under the registered business name M.C. Healthcare Products (“M.C. Healthcare”). Principles of Consolidation The consolidated financial statements include the accounts of the Company and Span - Canada, its wholly - owned subsidiary. Significant inter - entity accounts and transactions have been eliminated. Cash and Cash Equivalents We consider all highly liquid investments with a maturity when purchased of three may Accounts Receivable We provide credit in the normal course of business and perform ongoing credit evaluations on certain of our customers, but we generally do not require collateral to support these receivables. We also establish an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Account balances are charged against the allowance after all collection efforts have been exhausted and the potential for recovery is considered remote. Inventories Our inventories are valued at the lower of cost (first first Property and Equipment Property and equipment is stated at cost. Maintenance, repairs and minor replacements that do not improve or extend the useful lives of assets are expensed when incurred. Depreciation is computed using the straight - line method. Estimated useful lives for buildings and land improvements range from 5 35 3 10 Goodwill and Intangibles Intangible assets are amortized using the straight - line method. Costs of patents are amortized over 17 10 2.0 11.8 three may 5 6 Foreign Currency Translation Span - Canada uses the Canadian dollar as its functional currency. The assets and liabilities of Span - Canada are translated into U.S. dollars at the year - end exchange rate. Revenues and expenses are translated at weighted average exchange rates. The resulting translation adjustments are recorded as a separate component of shareholders' equity in “Accumulated Other Comprehensive Loss.” Revenue Recognition We recognize revenue when title and risk of loss pass to the customer and collection is reasonably assured. Our sales prices are fixed at the time revenue is recognized. There are no customer acceptance provisions, and the right to return exists only in cases of damaged product, non - compliance with customer specifications or warranty claims. Taxes collected from customers and remitted to government authorities are recorded on a net basis (excluded from revenues). We have applied the accounting and disclosure requirements of Securities and Exchange Commission Staff Accounting Bulletin (“SAB”) No. 104. Advertising Costs Advertising costs are expensed as incurred. Shipping and Handling Costs Shipping and handling costs that are not reimbursed by customers are charged to selling and marketing expenses and were approximately $2,215,000 2016, $2,113,000 2015, $2,123,000 2014. Customer Rebates We offer rebates to our distributors based on predetermined sales targets. These rebates vary by the type of product sold and by distributor and are based on a percentage of the applicable sales target. The rebate expense is charged as a reduction of gross sales. Rebate expense and the associated liability are calculated and recorded as the rebate - related revenue is recognized. Earnings Per Share of Common Stock Earnings per share of common stock are computed based on the weighted average number of shares outstanding during each period. Stock - Based Compensation We measure and recognize compensation expense for all stock - based payments at fair value. Stock - based payments include stock option grants. We grant options to purchase common stock to some of our employees under various plans at prices equal to the market value of the stock on the dates the options are granted. New shares of stock are issued upon share option exercise. We do not have treasury stock. The fair value of each option grant is estimated on the date of grant using the Black - Scholes option pricing model with the following weighted average assumptions for grants made in fiscal 2011: 2.54%; 2.50%; 43.02%; 9.0 2011. Fiscal Year Our fiscal year ends on the Saturday nearest to September 30. 2016 52 2015 2014 53 52 2017 52 Income Taxes The liability method is used in accounting for federal and state income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are projected to be in effect when the differences are expected to reverse. The Company’s practice is to recognize interest and penalties, if any, related to income tax matters as part of income tax expense. Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes and the disclosure of contingent assets and liabilities. Although these estimates are based on our knowledge of current events and actions planned for the future, the estimates may Recently Issued Accounting Standards In May 2014, five In August 2015, one first 2019. In July 2015, first first 2017. In November 2015, 2015 07, 740)." December 15, 2016, In January 2016, 2016 01, 825 10): 2016 01 December 15, 2017, In February 2016, 2016 02, 842). 2016 02 twelve twelve 2016 02 December 15, 2018. 2016 02 In March 2016, 2016 09 December 15, 2016, 2016 09 In June 2016, 2016 13, 326): December 15, 2019, In August 2016, 2016 15, 230): December 15, 2017. Other accounting standards that have been issued or proposed by the FASB or other standards - setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption. Subsequent Events In preparing these consolidated financial statements, we have evaluated events and transactions for potential recognition or disclosure through the issuance of the financial statements.

Note 2 - Fair Value of Financia

Note 2 - Fair Value of Financial Instruments	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Fair Value Disclosures [Text Block]	2. FAIR VALUE OF FINANCIAL INSTRUMENTS The Company accounts for the fair value measurements for financial assets and liabilities measured on a recurring basis as required by the Fair Value Measurements and Disclosures topic of the Financial Accounting Standards Board Accounting Standards Codification (“ASC”). This guidance establishes a framework for measuring fair value and expands disclosure about fair value measurements. That framework provides a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 Following is a brief description of these three Level 1 Level 2 Level 3 The asset’s or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level (with “3” Following is a description of the valuation methodologies used for assets measured at fair value. Cash value of life insurance policy: Valued at the cash surrender value of the life insurance policy as of the last business day of the fiscal year, as determined by the issuer of the insurance policy, which approximates fair value. The method described above may may The following table summarizes information on the fair value measurement of the Company’s assets as of October 1, 2016 October 3, 2015, Total Quoted prices in active markets (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Cash value of life insurance policies 2016 $ 2,697,465 - $ 2,697,465 - 2015 $ 2,543,192 - $ 2,543,192 -

Note 3 - Inventories

Note 3 - Inventories	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Inventory Disclosure [Text Block]	3. 2016 2015 Raw materials $ 5,476,393 $ 5,455,942 Work in process 678,753 338,296 Finished goods 1,807,296 3,521,801 Reserve for obsolescence (525,000 ) (570,000 ) $ 7,437,442 $ 8,746,039

Note 4 - Property and Equipment

Note 4 - Property and Equipment	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Property, Plant and Equipment Disclosure [Text Block]	4. 2016 2015 Land $ 469,718 $ 469,718 Land improvements 486,698 486,698 Buildings 7,003,652 6,941,084 Machinery and equipment 9,563,061 9,241,581 Furniture and fixtures 506,277 487,856 Construction in process 36,637 85,329 Automobiles 23,853 9,520 18,089,896 17,721,786 Less accumulated depreciation 13,973,826 13,185,682 $ 4,116,070 $ 4,536,104

Note 5 - Goodwill

Note 5 - Goodwill	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Goodwill Disclosure [Text Block]	5 . GOODWILL As of October 1, 2016 October 3, 2015, $3,937,676 $3,930,282, three On December 9, 2011, $7,394 2016 $361,561 $195,703 2015 2014, Under Canadian tax law, a portion of goodwill acquired in connection with an asset acquisition may 75%, $2,000,000, For the fiscal year ended October 1, 2016, three 350 20 35 no 2016. We calculate the estimated fair value of our reporting units by using an income approach, which includes internally developed discounted cash flow models. To determine fair value, we make assumptions about a number of internal and external factors. Significant assumptions used in the impairment analysis include financial projections of sales, expenses, profit margins, working capital requirements, capital expenditures, tax rates and discount rates. These assumptions are based on our historical operating results for each of our reporting units, our detailed operating plan for fiscal year 2017 2018 2021. may 1, 1A.

Note 6 - Intangibles

Note 6 - Intangibles	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Intangible Assets Disclosure [Text Block]	6. INTANGIBLES 2016 2015 Patents and trademarks $ 2,268,402 $ 2,203,673 Trade names 343,678 342,416 Non-competition agreements 150,601 150,048 Customer relationships 2,526,230 2,516,952 5,288,911 5,213,089 Less accumulated amortization (3,299,012 ) (2,998,327 ) Net intangibles $ 1,989,899 $ 2,214,762 On December 9, 2011, $3,980,000. October 1, 2016 October 3, 2015 $1,367,399 $1,115,246, $1,653,110 $1,894,170, In addition, we had patents and trademarks (net of accumulated amortization) of $ 336,789 as of October 1, 2016 $320,592 October 3, 2015. Amortization expense for intangibles, patents and trademarks during fiscal years 2016, 2015 2014 $295,092, $326,775 $394,169, five Estimated Amortization Fiscal Years Expense 2017 $ 285,000 2018 278,000 2019 276,000 2020 276,000 2021 273,000

Note 7 - Other Assets

Note 7 - Other Assets	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Other Assets Disclosure [Text Block]	7. OTHER ASSETS 2016 2015 Cash value of life insurance policies - Note 2 $ 2,697,465 $ 2,543,192 Other 212,275 410,464 $ 2,909,740 $ 2,953,656

Note 8 - Accrued and Sundry Lia

Note 8 - Accrued and Sundry Liabilities	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Accounts Payable and Accrued Liabilities Disclosure [Text Block]	8 . ACCRUED AND SUNDRY LIABILITIES 2016 2015 Salaries and other compensation $ 1,805,557 $ 1,448,935 Federal and state income taxes and sales taxes 301,045 567,295 Payroll taxes accrued and withheld 129,562 98,184 Property taxes 176,139 172,337 Medical insurance 249,245 273,403 Warranty reserve - Note 9 306,488 291,980 Customer rebates 601,876 247,137 Other 13,545 20,840 $ 3,583,457 $ 3,120,111

Note 9 - Product Warranties

Note 9 - Product Warranties	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Product Warranty Disclosure [Text Block]	9. We offer warranties of various lengths to our customers, depending on the specific product sold. The warranties require us to repair or replace non - performing products during the warranty period at no cost to the customer. At the time revenue is recognized for products covered by warranties, we record a liability for estimated costs that may secondary Changes in our product warranty liability for the years ended October 1, 2016 October 3, 2015 2016 2015 Accrued liability at beginning of year $ 291,980 $ 257,860 Increase in reserve 208,615 256,754 Expenses (194,107 ) (222,634 ) Accrued liability at end of year $ 306,488 $ 291,980

Note 10 - Revolving Credit Faci

Note 10 - Revolving Credit Facility	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Debt Disclosure [Text Block]	10. In May 2015, three April 30, 2018. one $5.0 no 50% The credit agreement is unsecured and accrues interest at a variable rate equal to 30 85 165 85 1.2795% January 2016, The credit facility includes financial covenants relating to tangible net worth and leverage ratios, and restricts mergers and acquisitions, assets sales, indebtedness, liens and capital expenditures without prior written consent of or waiver by the lending bank. Also, our subsidiary is not restricted in its ability to pay dividends or make distributions to us. Violation of loan covenants could result in the acceleration of the term of the credit agreement. The lending bank waived any event of default in connection with (1) $1.8 2015, 46% (2) $1.00 November 2014 January 7, 2015. September 29, 2015 261,310 $17.49 We paid approximately $5,000, $6,000 $13,000 2016, 2015 2014, No October 1, 2016.

Note 11 - Deferred Compensation

Note 11 - Deferred Compensation	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Compensation Related Costs, General [Text Block]	1 1 . DEFERRED COMPENSATION We are obligated to make fixed payments of approximately $114,000 $27,000 2016, $32,000 2015 $37,000 2014,

Note 12 - Equity Compensation

Note 12 - Equity Compensation	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	12. In January 2007, 2007 (“2007 February 2007. 2007 250,000 may 2007 may 250,000 75,000 may 2007 may 2007 December 31, 2016 2007 In March 1997, 1997 (“1997 1997 200,000 1997 1,000 20% 10 three 1997 October 20, 2007. 1997 1997 1997 Shown below is a summary of activity under the Company’s two Outstanding Exercisable Weighted Weighted Average Average Shares Number of Ex. Price Number of Ex. Price Available Shares Per Share Shares Per Share Balance at 9/28/13 190,500 119,405 $ 11.30 107,605 $ 10.90 Fiscal Year 2014 Granted Exercised (26,091 ) Forfeited Expired Unexercised (322 ) Balance at 9/27/14 190,500 92,992 11.53 89,592 11.40 Fiscal Year 2015 Granted Exercised (19,685 ) Forfeited Balance at 10/3/15 190,500 73,307 12.16 73,307 12.16 Fiscal Year 2016 Granted Exercised (21,157 ) Forfeited Balance at 10/1/16 190,500 52,150 $ 13.18 52,150 $ 13.18 Shown below is a summary of stock options outstanding and exercisable at fiscal year - end 2016. Outstanding Exercisable Weighted Weighted Average Weighted Average Remaining Average Ranges of Exercise Number of Ex. Price Contract Number of Ex. Price Prices Shares Per Share Life (yrs) Shares Per Share $9.34 - $ 9.34 16,150 $ 9.34 2.4 16,150 $ 9.34 14.90 - 14.90 36,000 14.90 4.1 36,000 14.90 $9.34 - $14.90 52,150 $ 13.18 3.6 52,150 $ 13.18

Note 13 - Income Taxes

Note 13 - Income Taxes	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Income Tax Disclosure [Text Block]	1 3 . INCOME TAXES Deferred income taxes reflect the net tax effects of temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of our deferred tax liabilities and assets as of October 1, 2016 October 3, 2015 2016 2015 Deferred tax liabilities: Depreciation $ (280,000 ) $ (383,000 ) Amortization (88,000 ) (99,000 ) Total deferred tax liabilities (368,000 ) (482,000 ) Deferred tax assets: Deferred compensation 101,000 131,000 Accrued expenses 364,000 302,000 Inventory 74,000 62,000 Other 21,000 (10,000 ) Total deferred tax assets 560,000 485,000 Net deferred tax assets $ 192,000 $ 3,000 We made cash income tax payments, net of refunds, of approximately $2,267,000, $524,000 $1,904,000 2016, 2015 2014, Federal, state and foreign income tax provisions consist of the following: 2016 2015 2014 Current: Federal $ 1,706,000 $ 1,166,000 $ 1,125,000 State 99,000 34,000 20,000 Foreign 210,000 349,000 (150,000 ) 2,015,000 1,549,000 995,000 Deferred: Federal (132,000 ) 102,000 (11,000 ) State (6,000 ) 8,000 1,000 Foreign (50,000 ) 13,000 53,000 (188,000 ) 123,000 43,000 Income tax expense $ 1,827,000 $ 1,672,000 $ 1,038,000 Income tax expense differs from the amounts computed by applying the statutory U.S. federal tax rate to income before income taxes as follows: 2016 2015 2014 Computed tax at the U.S. statutory rate $ 2,065,000 $ 1,926,000 $ 1,234,000 Increases (decreases): State income taxes, net of federal tax benefit 61,000 27,000 13,000 Differences between U.S. and foreign tax rates (98,000 ) (191,000 ) (27,000 ) Officer's life insurance (50,000 ) (15,000 ) (57,000 ) Domestic production deduction (168,000 ) (115,000 ) (116,000 ) Other, net 17,000 40,000 (9,000 ) Income tax expense $ 1,827,000 $ 1,672,000 $ 1,038,000 We have adopted the provisions under ASC Topic 740, 740”) fifty fifty not October 1, 2016 October 3, 2015. 2012 2012. Span - America files income tax returns in the U.S. and various state and local jurisdictions. Span - Canada files separate income tax returns in Canada on an annual basis. The resulting foreign income taxes and any applicable U.S. or foreign tax implications of intercompany transactions will be accounted for within the consolidated financial reporting of income taxes, per the requirements of ASC Topic 740. A provision has not been made for U.S. or additional foreign taxes on $2,718,000

Note 14 - Earnings Per Share of

Note 14 - Earnings Per Share of Common Stock	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Earnings Per Share [Text Block]	14. The following table sets forth the computation of basic and diluted earnings per share of common stock. 2016 2015 2014 Numerator for basic and diluted earnings per share: Net income $ 4,247,331 $ 3,993,398 $ 2,590,767 Denominator: Denominator for basic earnings per share: Weighted average shares 2,734,862 2,978,107 2,948,992 Effect of dilutive securities: Employee stock options 23,257 27,975 44,341 Denominator for diluted earnings per share: Adjusted weighted average shares and assumed conversions 2,758,119 3,006,082 2,993,333 Net income per share: Basic $ 1.55 $ 1.34 $ 0.88 Diluted $ 1.54 $ 1.33 $ 0.87

Note 15 - Employee Benefits and

Note 15 - Employee Benefits and Incentive Plans	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Pension and Other Postretirement Benefits Disclosure [Text Block]	1 5 . EMPLOYEE BENEFITS AND INCENTIVE PLANS We have a 401(k) 401(k) $205,000, $188,000 $184,000, 2016, 2015 2014

Note 16 - Related Party Transac

Note 16 - Related Party Transactions	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Related Party Transactions Disclosure [Text Block]	1 6 . RELATED - PARTY TRANSACTIONS The company repurchased 249,310 $4.36 October 1, 2015 October 9, 2015, 2016, 12,000 $210,000 261,310 9% September 29, 2015

Note 17 - Major Customers

Note 17 - Major Customers	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Concentration Risk Disclosure [Text Block]	1 7 . MAJOR CUSTOMERS The largest of our medical customers are distributors who sell our products to acute care hospitals and long - term care facilities throughout the United States and Canada. Sales to one 17% 2016 2014 18% 2015. We have a business relationship with other customers to distribute certain of our consumer products, which are part of our custom products segment. Sales to a former customer amounted to 6% 2016 10% 2015. 18%, 7% 16% 2016, 2015 2014, See Note 18

Note 18 - Operations and Indust

Note 18 - Operations and Industry Segments and Geographic Areas	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Segment Reporting Disclosure [Text Block]	1 8 . OPERATIONS AND INDUSTRY SEGMENTS AND GEOGRAPHIC AREAS For management and reporting purposes, we divide our business into two 2016 2015 2014 Net sales: Medical $ 46,345,525 $ 47,810,988 $ 42,334,896 Custom products 21,281,645 16,504,008 13,522,479 $ 67,627,170 $ 64,314,996 $ 55,857,375 Operating profit: Medical $ 6,040,202 $ 6,342,253 $ 3,966,605 Custom products 801,548 (234,948 ) 257,997 6,841,750 6,107,305 4,224,602 Corporate expense (759,486 ) (849,853 ) (614,022 ) Other income (expense) (7,933 ) 407,946 18,187 Income before income taxes $ 6,074,331 $ 5,665,398 $ 3,628,767 Identifiable assets: Medical $ 22,299,011 $ 20,886,470 $ 22,221,526 Custom products 4,344,914 7,172,290 3,991,467 Corporate 6,917,614 4,122,862 9,633,841 $ 33,561,539 $ 32,181,622 $ 35,846,834 Depreciation and amortization expenses: Operating: Medical $ 909,972 $ 977,922 $ 1,069,882 Custom products 269,405 243,342 218,234 Corporate 655 514 409 $ 1,180,032 $ 1,221,778 $ 1,288,525 Capital expenditures: Medical $ 322,310 $ 428,206 $ 595,002 Custom products 117,383 226,659 75,843 $ 439,693 $ 654,865 $ 670,845 Geographic Areas: 2016 2015 2014 Net sales: United States $ 60,850,466 $ 56,470,245 $ 49,804,659 Canada 5,798,244 7,704,410 5,922,543 Other 978,460 140,341 130,173 $ 67,627,170 $ 64,314,996 $ 55,857,375 Property and equipment, net: United States $ 3,541,623 $ 3,927,018 $ 4,181,361 Canada 574,447 609,086 706,735 $ 4,116,070 $ 4,536,104 $ 4,888,096 Goodwill: United States $ 1,924,131 $ 1,924,131 $ 1,924,131 Canada 2,013,545 2,006,151 2,367,712 $ 3,937,676 $ 3,930,282 $ 4,291,843 Intangibles, net: United States $ 308,710 $ 309,164 $ 303,456 Canada 1,681,189 1,905,598 2,556,804 $ 1,989,899 $ 2,214,762 $ 2,860,260 Total sales by industry segment include sales to unaffiliated customers as reported in our statements of income. In calculating operating profit, non - allocable general corporate expenses, interest expense, other income and income taxes are not included, but certain corporate operating expenses incurred for the benefit of all segments are included on an allocated basis. Identifiable assets are those assets that are used in the operations of each segment on an allocated basis. Amounts shown for corporate assets consist primarily of cash and cash surrender value of life insurance. Included in the consolidated balance sheet at October 1, 2016 October 3, 2015, $11,000,000 $10,000,000, 1A. We have several customers whose sales represent significant portions of sales in their respective business segments. Sales to one 24% 2016 2015 22% 2014. 11% 2016, 2015 2014. one 57% 2016, 29% 2015 66% 2014. 19% 2016 40% 2015. The manufacturing employees of our Span - Canada subsidiary, representing 18% October 31, 2018.

Note 19 - Operating Leases

Note 19 - Operating Leases	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Leases of Lessee Disclosure [Text Block]	19 . OPERATING LEASES We lease truck equipment in South Carolina. In addition, we lease a 15,000 $7,500 60 Rental expense for all operating leases was $404,000 2016, $373,000 2015, $375,000 2014. We have a five 50,000 at CAD $278,000 first two $295,000 December 2021.

Note 20 - Commitments and Conti

Note 20 - Commitments and Contingencies	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	2 0 . COMMITMENTS AND CONTINGENCIES We are committed to minimum purchases of $700,000 2020. 2016, 2015, 2014, $829,000, $823,000 $898,000, $30,000 From time to time we are defendants in legal actions involving claims arising in the normal course of business. We believe that, as a result of legal defenses and insurance arrangements with parties we believe to be financially capable, none of these actions, if determined adversely, should have a material adverse effect on our operations or financial condition.

Note 21 - Quarterly Financial D

Note 21 - Quarterly Financial Data (Unaudited)	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Quarterly Financial Information [Text Block]	21 . QUARTERLY FINANCIAL DATA (Unaudited) Quarterly Financial Data (Unaudited) (Amounts in thousands, except per share data) First Second Third Fourth Year For Fiscal 2016 Net sales $ 21,452 $ 14,853 $ 15,347 $ 15,975 $ 67,627 Gross profit 5,483 5,191 5,654 5,953 22,281 Operating income 1,556 1,160 1,486 1,879 6,082 Net income 1,143 758 935 1,412 4,247 Earnings per share Basic 0.42 0.28 0.34 0.51 1.55 Diluted 0.42 0.28 0.34 0.51 1.54 For Fiscal 2015 Net sales $ 15,721 $ 15,034 $ 15,813 $ 17,747 $ 64,315 Gross profit 5,449 4,982 5,441 5,765 21,636 Operating income 1,344 925 1,318 1,670 5,257 Net income 970 773 963 1,287 3,993 Earnings per share Basic 0.33 0.26 0.32 0.43 1.34 Diluted 0.32 0.26 0.32 0.43 1.33

Schedule VIII Valuation and Qua

Schedule VIII Valuation and Qualifying Accounts	12 Months Ended
	Oct. 01, 2016
Notes to Financial Statements
Schedule of Valuation and Qualifying Accounts Disclosure [Text Block]	Schedule VIII Valuation and Qualifying Accounts Balance at Charged to Balance at Beginning of Costs and Deductions- ( c ) End of Description Period Expenses Describe Adjustments Period Fiscal Year Ended October 1, 2016 Deducted from asset accounts: Reserve for uncollectible accounts $ 148,000 $ (9,007 ) $ - $ 1,007 $ 140,000 Reserve for obsolete inventory $ 570,000 $ 22,200 $ 35,200 (b) $ (32,000 ) $ 525,000 Fiscal Year Ended October 3, 2015 Deducted from asset accounts: Reserve for uncollectible accounts $ 302,000 $ 38,776 $ 192,776 (a) $ - $ 148,000 Reserve for obsolete inventory $ 497,000 $ 73,000 $ - $ - $ 570,000 Fiscal Year Ended September 27, 2014 Deducted from asset accounts: Reserve for uncollectible accounts $ 263,000 $ 128,925 $ 89,925 (a) $ - $ 302,000 Reserve for obsolete inventory $ 720,000 $ 90,803 $ 313,803 (b) $ - $ 497,000 (a) Uncollectible accounts written off (b) Inventory disposed of All other schedules for which provision is made in the applicable accounting regulations of the Securities and Exchange Commission are not required under the related instructions or are inapplicable, and therefore have been omitted.

Significant Accounting Policies

Significant Accounting Policies (Policies)	12 Months Ended
	Oct. 01, 2016
Accounting Policies [Abstract]
Consolidation, Policy [Policy Text Block]	Principles of Consolidation The consolidated financial statements include the accounts of the Company and Span - Canada, its wholly - owned subsidiary. Significant inter - entity accounts and transactions have been eliminated.
Cash and Cash Equivalents, Policy [Policy Text Block]	Cash and Cash Equivalents We consider all highly liquid investments with a maturity when purchased of three may
Receivables, Policy [Policy Text Block]	Accounts Receivable We provide credit in the normal course of business and perform ongoing credit evaluations on certain of our customers, but we generally do not require collateral to support these receivables. We also establish an allowance for doubtful accounts based upon factors surrounding the credit risk of specific customers, historical trends and other information. Account balances are charged against the allowance after all collection efforts have been exhausted and the potential for recovery is considered remote.
Inventory, Policy [Policy Text Block]	Inventories Our inventories are valued at the lower of cost (first first
Property, Plant and Equipment, Policy [Policy Text Block]	Property and Equipment Property and equipment is stated at cost. Maintenance, repairs and minor replacements that do not improve or extend the useful lives of assets are expensed when incurred. Depreciation is computed using the straight - line method. Estimated useful lives for buildings and land improvements range from 5 35 3 10
Goodwill and Intangible Assets, Policy [Policy Text Block]	Goodwill and Intangibles Intangible assets are amortized using the straight - line method. Costs of patents are amortized over 17 10 2.0 11.8 three may 5 6
Foreign Currency Transactions and Translations Policy [Policy Text Block]	Foreign Currency Translation Span - Canada uses the Canadian dollar as its functional currency. The assets and liabilities of Span - Canada are translated into U.S. dollars at the year - end exchange rate. Revenues and expenses are translated at weighted average exchange rates. The resulting translation adjustments are recorded as a separate component of shareholders' equity in “Accumulated Other Comprehensive Loss.”
Revenue Recognition, Policy [Policy Text Block]	Revenue Recognition We recognize revenue when title and risk of loss pass to the customer and collection is reasonably assured. Our sales prices are fixed at the time revenue is recognized. There are no customer acceptance provisions, and the right to return exists only in cases of damaged product, non - compliance with customer specifications or warranty claims. Taxes collected from customers and remitted to government authorities are recorded on a net basis (excluded from revenues). We have applied the accounting and disclosure requirements of Securities and Exchange Commission Staff Accounting Bulletin (“SAB”) No. 104.
Advertising Cost, Policy, Expensed Advertising Cost [Policy Text Block]	Advertising Costs Advertising costs are expensed as incurred.
Shipping and Handling Cost, Policy [Policy Text Block]	Shipping and Handling Costs Shipping and handling costs that are not reimbursed by customers are charged to selling and marketing expenses and were approximately $2,215,000 2016, $2,113,000 2015, $2,123,000 2014.
Revenue Recognition, Rebates [Policy Text Block]	Customer Rebates We offer rebates to our distributors based on predetermined sales targets. These rebates vary by the type of product sold and by distributor and are based on a percentage of the applicable sales target. The rebate expense is charged as a reduction of gross sales. Rebate expense and the associated liability are calculated and recorded as the rebate - related revenue is recognized.
Earnings Per Share, Policy [Policy Text Block]	Earnings Per Share of Common Stock Earnings per share of common stock are computed based on the weighted average number of shares outstanding during each period.
Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]	Stock - Based Compensation We measure and recognize compensation expense for all stock - based payments at fair value. Stock - based payments include stock option grants. We grant options to purchase common stock to some of our employees under various plans at prices equal to the market value of the stock on the dates the options are granted. New shares of stock are issued upon share option exercise. We do not have treasury stock. The fair value of each option grant is estimated on the date of grant using the Black - Scholes option pricing model with the following weighted average assumptions for grants made in fiscal 2011: 2.54%; 2.50%; 43.02%; 9.0 2011.
Fiscal Period, Policy [Policy Text Block]	Fiscal Year Our fiscal year ends on the Saturday nearest to September 30. 2016 52 2015 2014 53 52 2017 52
Income Tax, Policy [Policy Text Block]	Income Taxes The liability method is used in accounting for federal and state income taxes. Under this method, deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that are projected to be in effect when the differences are expected to reverse. The Company’s practice is to recognize interest and penalties, if any, related to income tax matters as part of income tax expense.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes and the disclosure of contingent assets and liabilities. Although these estimates are based on our knowledge of current events and actions planned for the future, the estimates may
New Accounting Pronouncements, Policy [Policy Text Block]	Recently Issued Accounting Standards In May 2014, five In August 2015, one first 2019. In July 2015, first first 2017. In November 2015, 2015 07, 740)." December 15, 2016, In January 2016, 2016 01, 825 10): 2016 01 December 15, 2017, In February 2016, 2016 02, 842). 2016 02 twelve twelve 2016 02 December 15, 2018. 2016 02 In March 2016, 2016 09 December 15, 2016, 2016 09 In June 2016, 2016 13, 326): December 15, 2019, In August 2016, 2016 15, 230): December 15, 2017. Other accounting standards that have been issued or proposed by the FASB or other standards - setting bodies that do not require adoption until a future date are not expected to have a material impact on our financial statements upon adoption.
Subsequent Events, Policy [Policy Text Block]	Subsequent Events In preparing these consolidated financial statements, we have evaluated events and transactions for potential recognition or disclosure through the issuance of the financial statements.

Note 2 - Fair Value of Financ32

Note 2 - Fair Value of Financial Instruments (Tables)	12 Months Ended
	Oct. 01, 2016
Notes Tables
Fair Value, Assets Measured on Recurring and Nonrecurring Basis [Table Text Block]	Total Quoted prices in active markets (Level 1) Significant other observable inputs (Level 2) Significant unobservable inputs (Level 3) Cash value of life insurance policies 2016 $ 2,697,465 - $ 2,697,465 - 2015 $ 2,543,192 - $ 2,543,192 -

Note 3 - Inventories (Tables)

Note 3 - Inventories (Tables)	12 Months Ended
	Oct. 01, 2016
Notes Tables
Schedule of Inventory, Current [Table Text Block]	2016 2015 Raw materials $ 5,476,393 $ 5,455,942 Work in process 678,753 338,296 Finished goods 1,807,296 3,521,801 Reserve for obsolescence (525,000 ) (570,000 ) $ 7,437,442 $ 8,746,039

Note 4 - Property and Equipme34

Note 4 - Property and Equipment (Tables)	12 Months Ended
	Oct. 01, 2016
Notes Tables
Property, Plant and Equipment [Table Text Block]	2016 2015 Land $ 469,718 $ 469,718 Land improvements 486,698 486,698 Buildings 7,003,652 6,941,084 Machinery and equipment 9,563,061 9,241,581 Furniture and fixtures 506,277 487,856 Construction in process 36,637 85,329 Automobiles 23,853 9,520 18,089,896 17,721,786 Less accumulated depreciation 13,973,826 13,185,682 $ 4,116,070 $ 4,536,104

Note 6 - Intangibles (Tables)

Note 6 - Intangibles (Tables)	12 Months Ended
	Oct. 01, 2016
Notes Tables
Schedule of Finite-Lived Intangible Assets [Table Text Block]	2016 2015 Patents and trademarks $ 2,268,402 $ 2,203,673 Trade names 343,678 342,416 Non-competition agreements 150,601 150,048 Customer relationships 2,526,230 2,516,952 5,288,911 5,213,089 Less accumulated amortization (3,299,012 ) (2,998,327 ) Net intangibles $ 1,989,899 $ 2,214,762
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]	Estimated Amortization Fiscal Years Expense 2017 $ 285,000 2018 278,000 2019 276,000 2020 276,000 2021 273,000

Note 7 - Other Assets (Tables)

Note 7 - Other Assets (Tables)	12 Months Ended
	Oct. 01, 2016
Notes Tables
Schedule of Other Assets, Noncurrent [Table Text Block]	2016 2015 Cash value of life insurance policies - Note 2 $ 2,697,465 $ 2,543,192 Other 212,275 410,464 $ 2,909,740 $ 2,953,656

Note 8 - Accrued and Sundry L37

Note 8 - Accrued and Sundry Liabilities (Tables)	12 Months Ended
	Oct. 01, 2016
Notes Tables
Schedule of Accrued Liabilities [Table Text Block]	2016 2015 Salaries and other compensation $ 1,805,557 $ 1,448,935 Federal and state income taxes and sales taxes 301,045 567,295 Payroll taxes accrued and withheld 129,562 98,184 Property taxes 176,139 172,337 Medical insurance 249,245 273,403 Warranty reserve - Note 9 306,488 291,980 Customer rebates 601,876 247,137 Other 13,545 20,840 $ 3,583,457 $ 3,120,111

Note 9 - Product Warranties (Ta

Note 9 - Product Warranties (Tables)	12 Months Ended
	Oct. 01, 2016
Notes Tables
Schedule of Product Warranty Liability [Table Text Block]	2016 2015 Accrued liability at beginning of year $ 291,980 $ 257,860 Increase in reserve 208,615 256,754 Expenses (194,107 ) (222,634 ) Accrued liability at end of year $ 306,488 $ 291,980

Note 12 - Equity Compensation (

Note 12 - Equity Compensation (Tables)	12 Months Ended
	Oct. 01, 2016
Notes Tables
Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]	Outstanding Exercisable Weighted Weighted Average Average Shares Number of Ex. Price Number of Ex. Price Available Shares Per Share Shares Per Share Balance at 9/28/13 190,500 119,405 $ 11.30 107,605 $ 10.90 Fiscal Year 2014 Granted Exercised (26,091 ) Forfeited Expired Unexercised (322 ) Balance at 9/27/14 190,500 92,992 11.53 89,592 11.40 Fiscal Year 2015 Granted Exercised (19,685 ) Forfeited Balance at 10/3/15 190,500 73,307 12.16 73,307 12.16 Fiscal Year 2016 Granted Exercised (21,157 ) Forfeited Balance at 10/1/16 190,500 52,150 $ 13.18 52,150 $ 13.18
Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range [Table Text Block]	Outstanding Exercisable Weighted Weighted Average Weighted Average Remaining Average Ranges of Exercise Number of Ex. Price Contract Number of Ex. Price Prices Shares Per Share Life (yrs) Shares Per Share $9.34 - $ 9.34 16,150 $ 9.34 2.4 16,150 $ 9.34 14.90 - 14.90 36,000 14.90 4.1 36,000 14.90 $9.34 - $14.90 52,150 $ 13.18 3.6 52,150 $ 13.18

Note 13 - Income Taxes (Tables)

Note 13 - Income Taxes (Tables)	12 Months Ended
	Oct. 01, 2016
Notes Tables
Schedule of Deferred Tax Assets and Liabilities [Table Text Block]	2016 2015 Deferred tax liabilities: Depreciation $ (280,000 ) $ (383,000 ) Amortization (88,000 ) (99,000 ) Total deferred tax liabilities (368,000 ) (482,000 ) Deferred tax assets: Deferred compensation 101,000 131,000 Accrued expenses 364,000 302,000 Inventory 74,000 62,000 Other 21,000 (10,000 ) Total deferred tax assets 560,000 485,000 Net deferred tax assets $ 192,000 $ 3,000
Schedule of Components of Income Tax Expense (Benefit) [Table Text Block]	2016 2015 2014 Current: Federal $ 1,706,000 $ 1,166,000 $ 1,125,000 State 99,000 34,000 20,000 Foreign 210,000 349,000 (150,000 ) 2,015,000 1,549,000 995,000 Deferred: Federal (132,000 ) 102,000 (11,000 ) State (6,000 ) 8,000 1,000 Foreign (50,000 ) 13,000 53,000 (188,000 ) 123,000 43,000 Income tax expense $ 1,827,000 $ 1,672,000 $ 1,038,000
Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]	2016 2015 2014 Computed tax at the U.S. statutory rate $ 2,065,000 $ 1,926,000 $ 1,234,000 Increases (decreases): State income taxes, net of federal tax benefit 61,000 27,000 13,000 Differences between U.S. and foreign tax rates (98,000 ) (191,000 ) (27,000 ) Officer's life insurance (50,000 ) (15,000 ) (57,000 ) Domestic production deduction (168,000 ) (115,000 ) (116,000 ) Other, net 17,000 40,000 (9,000 ) Income tax expense $ 1,827,000 $ 1,672,000 $ 1,038,000

Note 14 - Earnings Per Share 41

Note 14 - Earnings Per Share of Common Stock (Tables)	12 Months Ended
	Oct. 01, 2016
Notes Tables
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	2016 2015 2014 Numerator for basic and diluted earnings per share: Net income $ 4,247,331 $ 3,993,398 $ 2,590,767 Denominator: Denominator for basic earnings per share: Weighted average shares 2,734,862 2,978,107 2,948,992 Effect of dilutive securities: Employee stock options 23,257 27,975 44,341 Denominator for diluted earnings per share: Adjusted weighted average shares and assumed conversions 2,758,119 3,006,082 2,993,333 Net income per share: Basic $ 1.55 $ 1.34 $ 0.88 Diluted $ 1.54 $ 1.33 $ 0.87

Note 18 - Operations and Indu42

Note 18 - Operations and Industry Segments and Geographic Areas (Tables)	12 Months Ended
	Oct. 01, 2016
Notes Tables
Schedule of Segment Reporting Information, by Segment [Table Text Block]	2016 2015 2014 Net sales: Medical $ 46,345,525 $ 47,810,988 $ 42,334,896 Custom products 21,281,645 16,504,008 13,522,479 $ 67,627,170 $ 64,314,996 $ 55,857,375 Operating profit: Medical $ 6,040,202 $ 6,342,253 $ 3,966,605 Custom products 801,548 (234,948 ) 257,997 6,841,750 6,107,305 4,224,602 Corporate expense (759,486 ) (849,853 ) (614,022 ) Other income (expense) (7,933 ) 407,946 18,187 Income before income taxes $ 6,074,331 $ 5,665,398 $ 3,628,767 Identifiable assets: Medical $ 22,299,011 $ 20,886,470 $ 22,221,526 Custom products 4,344,914 7,172,290 3,991,467 Corporate 6,917,614 4,122,862 9,633,841 $ 33,561,539 $ 32,181,622 $ 35,846,834 Depreciation and amortization expenses: Operating: Medical $ 909,972 $ 977,922 $ 1,069,882 Custom products 269,405 243,342 218,234 Corporate 655 514 409 $ 1,180,032 $ 1,221,778 $ 1,288,525 Capital expenditures: Medical $ 322,310 $ 428,206 $ 595,002 Custom products 117,383 226,659 75,843 $ 439,693 $ 654,865 $ 670,845 Geographic Areas: 2016 2015 2014 Net sales: United States $ 60,850,466 $ 56,470,245 $ 49,804,659 Canada 5,798,244 7,704,410 5,922,543 Other 978,460 140,341 130,173 $ 67,627,170 $ 64,314,996 $ 55,857,375 Property and equipment, net: United States $ 3,541,623 $ 3,927,018 $ 4,181,361 Canada 574,447 609,086 706,735 $ 4,116,070 $ 4,536,104 $ 4,888,096 Goodwill: United States $ 1,924,131 $ 1,924,131 $ 1,924,131 Canada 2,013,545 2,006,151 2,367,712 $ 3,937,676 $ 3,930,282 $ 4,291,843 Intangibles, net: United States $ 308,710 $ 309,164 $ 303,456 Canada 1,681,189 1,905,598 2,556,804 $ 1,989,899 $ 2,214,762 $ 2,860,260

Note 21 - Quarterly Financial43

Note 21 - Quarterly Financial Data (Unaudited) (Tables)	12 Months Ended
	Oct. 01, 2016
Notes Tables
Quarterly Financial Information [Table Text Block]	First Second Third Fourth Year For Fiscal 2016 Net sales $ 21,452 $ 14,853 $ 15,347 $ 15,975 $ 67,627 Gross profit 5,483 5,191 5,654 5,953 22,281 Operating income 1,556 1,160 1,486 1,879 6,082 Net income 1,143 758 935 1,412 4,247 Earnings per share Basic 0.42 0.28 0.34 0.51 1.55 Diluted 0.42 0.28 0.34 0.51 1.54 For Fiscal 2015 Net sales $ 15,721 $ 15,034 $ 15,813 $ 17,747 $ 64,315 Gross profit 5,449 4,982 5,441 5,765 21,636 Operating income 1,344 925 1,318 1,670 5,257 Net income 970 773 963 1,287 3,993 Earnings per share Basic 0.33 0.26 0.32 0.43 1.34 Diluted 0.32 0.26 0.32 0.43 1.33

Schedule VIII Valuation and Q44

Schedule VIII Valuation and Qualifying Accounts (Tables)	12 Months Ended
	Oct. 01, 2016
Notes Tables
Valuation and Qualifying Accounts [Table Text Block]	Schedule VIII Valuation and Qualifying Accounts Balance at Charged to Balance at Beginning of Costs and Deductions- ( c ) End of Description Period Expenses Describe Adjustments Period Fiscal Year Ended October 1, 2016 Deducted from asset accounts: Reserve for uncollectible accounts $ 148,000 $ (9,007 ) $ - $ 1,007 $ 140,000 Reserve for obsolete inventory $ 570,000 $ 22,200 $ 35,200 (b) $ (32,000 ) $ 525,000 Fiscal Year Ended October 3, 2015 Deducted from asset accounts: Reserve for uncollectible accounts $ 302,000 $ 38,776 $ 192,776 (a) $ - $ 148,000 Reserve for obsolete inventory $ 497,000 $ 73,000 $ - $ - $ 570,000 Fiscal Year Ended September 27, 2014 Deducted from asset accounts: Reserve for uncollectible accounts $ 263,000 $ 128,925 $ 89,925 (a) $ - $ 302,000 Reserve for obsolete inventory $ 720,000 $ 90,803 $ 313,803 (b) $ - $ 497,000

Note 1 - Significant Accounti45

Note 1 - Significant Accounting Policies (Details Textual) - USD ($)	12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014	Oct. 01, 2011
Shipping, Handling and Transportation Costs	$ 2,215,000	$ 2,113,000	$ 2,123,000
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate				2.54%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate				2.50%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate				43.02%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term				9 years
Patents [Member]
Finite-Lived Intangible Asset, Useful Life	17 years
Trademarks [Member]
Finite-Lived Intangible Asset, Useful Life	10 years
Minimum [Member] | M C H P Acquisition Trade Names Non Compete Agreements And Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life	2 years
Maximum [Member] | M C H P Acquisition Trade Names Non Compete Agreements And Customer Relationships [Member]
Finite-Lived Intangible Asset, Useful Life	11 years 292 days
Land, Buildings and Improvements [Member] | Minimum [Member]
Property, Plant and Equipment, Useful Life	5 years
Land, Buildings and Improvements [Member] | Maximum [Member]
Property, Plant and Equipment, Useful Life	35 years
Property, Plant and Equipment, Other Types [Member] | Minimum [Member]
Property, Plant and Equipment, Useful Life	3 years
Property, Plant and Equipment, Other Types [Member] | Maximum [Member]
Property, Plant and Equipment, Useful Life	10 years

Note 2 - Fair Value of Financ46

Note 2 - Fair Value of Financial Instruments - Fair Value Measurement of Assets (Details) - USD ($)	Oct. 01, 2016	Oct. 03, 2015
Cash value of life insurance policies	$ 2,697,465	$ 2,543,192
Fair Value, Inputs, Level 2 [Member]
Cash value of life insurance policies	$ 2,697,465	$ 2,543,192

Note 3 - Inventories - Componen

Note 3 - Inventories - Components of Inventories (Details) - USD ($)	Oct. 01, 2016	Oct. 03, 2015
Raw materials	$ 5,476,393	$ 5,455,942
Work in process	678,753	338,296
Finished goods	1,807,296	3,521,801
Reserve for obsolescence	(525,000)	(570,000)
	$ 7,437,442	$ 8,746,039

Note 4 - Property and Equipme48

Note 4 - Property and Equipment - Property and Equipment (Details) - USD ($)	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Land	$ 469,718	$ 469,718
Land improvements	486,698	486,698
Buildings	7,003,652	6,941,084
Machinery and equipment	9,563,061	9,241,581
Furniture and fixtures	506,277	487,856
Construction in process	36,637	85,329
Automobiles	23,853	9,520
	18,089,896	17,721,786
Less accumulated depreciation	13,973,826	13,185,682
	$ 4,116,070	$ 4,536,104	$ 4,888,096

Note 5 - Goodwill (Details Text

Note 5 - Goodwill (Details Textual)	12 Months Ended
	Oct. 01, 2016USD ($)	Oct. 03, 2015USD ($)	Sep. 27, 2014USD ($)
Goodwill	$ 3,937,676	$ 3,930,282	$ 4,291,843
Number of Reporting Units	3
Goodwill, Foreign Currency Translation Gain (Loss)	$ 7,394	$ (361,561)	$ (195,703)
Goodwill, Impairment Loss	$ 0
M.C. Healthcare Products "MCHP" [Member] | Canada Revenue Agency [Member]
Percentage of Goodwill Deductible Under Canadian Tax Law	75.00%
Business Acquisition, Goodwill, Expected Tax Deductible Amount	$ 2,000,000

Note 6 - Intangibles (Details T

Note 6 - Intangibles (Details Textual) - USD ($)	12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014	Dec. 09, 2011
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles				$ 3,980,000
Finite-Lived Intangible Assets, Accumulated Amortization	$ 3,299,012	$ 2,998,327
Finite-Lived Intangible Assets, Net	1,989,899	2,214,762
Amortization of Intangible Assets	295,092	326,775	$ 394,169
Patents and Trademarks [Member]
Finite-Lived Intangible Assets, Net	336,789	320,592
M.C. Healthcare Products "MCHP" [Member] | M C H P Acquisition Trade Names Non Compete Agreements And Customer Relationships [Member]
Finite-Lived Intangible Assets, Accumulated Amortization	1,367,399	1,115,246
Finite-Lived Intangible Assets, Net	$ 1,653,110	$ 1,894,170

Note 6 - Intangibles - Intangib

Note 6 - Intangibles - Intangibles (Details) - USD ($)	Oct. 01, 2016	Oct. 03, 2015
Patents and trademarks	$ 2,268,402	$ 2,203,673
Trade names	343,678	342,416
Non-competition agreements	150,601	150,048
Customer relationships	2,526,230	2,516,952
	5,288,911	5,213,089
Less accumulated amortization	(3,299,012)	(2,998,327)
Net intangibles	$ 1,989,899	$ 2,214,762

Note 6 - Intangibles - Estimate

Note 6 - Intangibles - Estimated Amortization Expense (Details)	Oct. 01, 2016USD ($)
2,016	$ 285,000
2,017	278,000
2,018	276,000
2,019	276,000
2,020	$ 273,000

Note 7 - Other Assets - Other A

Note 7 - Other Assets - Other Assets (Details) - USD ($)	Oct. 01, 2016	Oct. 03, 2015
Cash value of life insurance policies - Note 2	$ 2,697,465	$ 2,543,192
Other	212,275	410,464
	$ 2,909,740	$ 2,953,656

Note 8 - Accrued and Sundry L54

Note 8 - Accrued and Sundry Liabilities - Accrued and Sundry Liabilities (Details) - USD ($)	Oct. 01, 2016	Oct. 03, 2015
Salaries and other compensation	$ 1,805,557	$ 1,448,935
Federal and state income taxes and sales taxes	301,045	567,295
Payroll taxes accrued and withheld	129,562	98,184
Property taxes	176,139	172,337
Medical insurance	249,245	273,403
Warranty reserve - Note 9	306,488	291,980
Customer rebates	601,876	247,137
Other	13,545	20,840
	$ 3,583,457	$ 3,120,111

Note 9 - Product Warranties - C

Note 9 - Product Warranties - Changes in Product Warranty Liability (Details) - USD ($)	12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015
Accrued liability at beginning of year	$ 291,980	$ 257,860
Increase in reserve	208,615	256,754
Expenses	(194,107)	(222,634)
Accrued liability at end of year	$ 306,488	$ 291,980

Note 10 - Revolving Credit Fa56

Note 10 - Revolving Credit Facility (Details Textual) - USD ($)	1 Months Ended	2 Months Ended	12 Months Ended
	May 31, 2015	Jan. 07, 2015	Oct. 01, 2016	Oct. 03, 2015	Sep. 29, 2015	Sep. 27, 2014	Jan. 31, 2016
Line of Credit Facility, Interest Rate at Period End							1.2795%
Payments of Dividends			$ 1,752,004	$ 4,780,572		$ 1,683,011
Dividends Paid, Percentage of Net Income				46.00%
Common Stock, Dividends, Per Share, Cash Paid		$ 1
Interest Expense			$ 5,144	$ 6,285		$ 12,639
Non-Special Dividend [Member]
Payments of Dividends				$ 1,800,000
London Interbank Offered Rate (LIBOR) [Member] | Minimum [Member]
Debt Instrument, Basis Spread on Variable Rate			85.00%
London Interbank Offered Rate (LIBOR) [Member] | Maximum [Member]
Debt Instrument, Basis Spread on Variable Rate			165.00%
Revolving Credit Facility [Member]
Debt Instrument, Term	3 years
Line of Credit Facility, Maximum Borrowing Capacity	$ 5,000,000
Line of Credit Facility, Commitment Fee Amount	$ 0
Debt Instrument, Covenants, Lender's Consent, Number of Shares to be Repurchased					261,310
Stock Repurchased Price per Share					$ 17.49
Long-term Line of Credit			$ 0

Note 11 - Deferred Compensati57

Note 11 - Deferred Compensation (Details Textual) - USD ($)	12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Deferred Compensation Arrangement with Individual, Compensation Expense	$ 27,000	$ 32,000	$ 37,000
Founder and Former Chief Executive Office and His Ex Wife [Member]
Deferred Compensation Arrangement, Annual Payment	$ 114,000

Note 12 - Equity Compensation58

Note 12 - Equity Compensation (Details Textual) - shares	1 Months Ended
	Mar. 31, 1997	Feb. 28, 2007
The 2007 Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		250,000
The 2007 Equity Incentive Plan [Member] | Restricted Stock, Non-restricted Stock or Restricted Stock Units [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized		75,000
The 1997 Stock Option Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	200,000
Share-based Compensation Arrangement by Share-based Payment Award Award Vesting Rights Shares Vesting Per Year	1,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage	20.00%
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period	10 years
Share-based Compensation Arrangement by Share-based Payment Award, Termination of Employment, Expiration Period	90 days

Note 12 - Equity Compensation -

Note 12 - Equity Compensation - Summary of Activity Under Two Stock Option Plans (Details) - $ / shares	12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014	Sep. 28, 2013
Shares Available for Grant (in shares)	190,500	190,500	190,500	190,500
Number of Shares, Outstanding (in shares)	52,150	73,307	92,992	119,405
Weighted Average Ex. Price Per Share, Outstanding (in dollars per share)	$ 13.18	$ 12.16	$ 11.53	$ 11.30
Number of Shares, Exercisable (in shares)	52,150	73,307	89,592	107,605
Weighted Average Ex. Price Per Share, Exercisable (in dollars per share)	$ 13.18	$ 12.16	$ 11.40	$ 10.90
Shares Outstanding, Exercised (in shares)	(21,157)	(19,685)	(26,091)
Shares Outstanding, Expired Unexercised (in shares)			(322)

Note 12 - Equity Compensation60

Note 12 - Equity Compensation - Summary of Stock Options Outstanding and Exercisable (Details)	12 Months Ended
	Oct. 01, 2016$ / sharesshares
Exercise Price Range 1 [Member]
Exercise Price Lower Range Limit (in dollars per share)	$ 9.34
Exercise Price Upper Range Limit (in dollars per share)	$ 9.34
Number of Shares, Outstanding (in shares) | shares	16,150
Weighted Average Ex. Price Per Share, Outstanding (in dollars per share)	$ 9.34
Weighted Average Remaining Contract Life (yrs), Outstanding (Year)	2 years 146 days
Number of Shares, Exercisable (in shares) | shares	16,150
Weighted Average Ex. Price Per Share, Exercisable (Year)	9 years 124 days
Exercise Price Range 2 [Member]
Exercise Price Lower Range Limit (in dollars per share)	$ 14.90
Exercise Price Upper Range Limit (in dollars per share)	$ 14.90
Number of Shares, Outstanding (in shares) | shares	36,000
Weighted Average Ex. Price Per Share, Outstanding (in dollars per share)	$ 14.90
Weighted Average Remaining Contract Life (yrs), Outstanding (Year)	4 years 36 days
Number of Shares, Exercisable (in shares) | shares	36,000
Weighted Average Ex. Price Per Share, Exercisable (Year)	14 years 328 days
Exercise Price Range 3 [Member]
Exercise Price Lower Range Limit (in dollars per share)	$ 9.34
Exercise Price Upper Range Limit (in dollars per share)	$ 14.90
Number of Shares, Outstanding (in shares) | shares	52,150
Weighted Average Ex. Price Per Share, Outstanding (in dollars per share)	$ 13.18
Weighted Average Remaining Contract Life (yrs), Outstanding (Year)	3 years 219 days
Number of Shares, Exercisable (in shares) | shares	52,150
Weighted Average Ex. Price Per Share, Exercisable (Year)	13 years 65 days

Note 13 - Income Taxes (Details

Note 13 - Income Taxes (Details Textual) - USD ($)	12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Income Taxes Paid, Net	$ 2,267,000	$ 524,000	$ 1,904,000
Liability for Uncertainty in Income Taxes, Noncurrent	0	$ 0
Undistributed Earnings of Foreign Subsidiaries	$ 2,718,000

Note 13 - Income Taxes - Deferr

Note 13 - Income Taxes - Deferred Tax Liabilities and Assets (Details) - USD ($)	Oct. 01, 2016	Oct. 03, 2015
Deferred tax liabilities:
Depreciation	$ (280,000)	$ (383,000)
Amortization	(88,000)	(99,000)
Total deferred tax liabilities	(368,000)	(482,000)
Deferred tax assets:
Deferred compensation	101,000	131,000
Accrued expenses	364,000	302,000
Inventory	74,000	62,000
Other	21,000	(10,000)
Total deferred tax assets	560,000	485,000
Net deferred tax assets	$ 192,000	$ 3,000

Note 13 - Income Taxes - Federa

Note 13 - Income Taxes - Federal, State and Foreign Income Tax Provisions (Details) - USD ($)	12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Current:
Federal	$ 1,706,000	$ 1,166,000	$ 1,125,000
State	99,000	34,000	20,000
Foreign	210,000	349,000	(150,000)
	2,015,000	1,549,000	995,000
Deferred:
Federal	(132,000)	102,000	(11,000)
State	(6,000)	8,000	1,000
Foreign	(50,000)	13,000	53,000
	(188,000)	123,000	43,000
Income tax expense	$ 1,827,000	$ 1,672,000	$ 1,038,000

Note 13 - Income Taxes - Effect

Note 13 - Income Taxes - Effective Income Tax Rate Reconciliation (Details) - USD ($)	12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Computed tax at the U.S. statutory rate	$ 2,065,000	$ 1,926,000	$ 1,234,000
Increases (decreases):
State income taxes, net of federal tax benefit	61,000	27,000	13,000
Differences between U.S. and foreign tax rates	(98,000)	(191,000)	(27,000)
Officer's life insurance	(50,000)	(15,000)	(57,000)
Domestic production deduction	(168,000)	(115,000)	(116,000)
Other, net	17,000	40,000	(9,000)
Income tax expense	$ 1,827,000	$ 1,672,000	$ 1,038,000

Note 14 - Earnings Per Share 65

Note 14 - Earnings Per Share of Common Stock - Basic and Diluted Earnings Per Share (Details) - USD ($)	3 Months Ended								12 Months Ended
	Oct. 01, 2016	Jul. 02, 2016	Apr. 02, 2016	Jan. 02, 2016	Oct. 03, 2015	Jul. 01, 2015	Mar. 31, 2015	Dec. 29, 2014	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Numerator for basic and diluted earnings per share:
Net income	$ 1,412,000	$ 935,000	$ 758,000	$ 1,143,000	$ 1,287,000	$ 963,000	$ 773,000	$ 970,000	$ 4,247,331	$ 3,993,398	$ 2,590,767
Denominator for basic earnings per share:
Weighted average shares (in shares)									2,734,862	2,978,107	2,948,992
Effect of dilutive securities:
Employee stock options (in shares)									23,257	27,975	44,341
Weighted average shares outstanding:
Adjusted weighted average shares and assumed conversions (in shares)									2,758,119	3,006,082	2,993,333
Net income per share:
Basic (in dollars per share)	$ 0.51	$ 0.34	$ 0.28	$ 0.42	$ 0.43	$ 0.32	$ 0.26	$ 0.33	$ 1.55	$ 1.34	$ 0.88
Diluted (in dollars per share)	$ 0.51	$ 0.34	$ 0.28	$ 0.42	$ 0.43	$ 0.32	$ 0.26	$ 0.32	$ 1.54	$ 1.33	$ 0.87

Note 15 - Employee Benefits a66

Note 15 - Employee Benefits and Incentive Plans (Details Textual) - USD ($)	12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Defined Contribution Plan, Employer Discretionary Contribution Amount	$ 205,000	$ 188,000	$ 184,000

Note 16 - Related Party Trans67

Note 16 - Related Party Transactions (Details Textual) - USD ($)	Oct. 09, 2015	Oct. 01, 2015	Oct. 01, 2016	Oct. 03, 2015
Stock Repurchased and Retired During Period, Value			$ 209,880	$ 4,437,251
Share Repurchase Program [Member]
Stock Repurchased and Retired During Period, Shares	261,310
Percentage of Repurchased Common Stock Shares to Total Outstanding Shares	9.00%
The Jerry Zucker Revocable Trust [Member] | Share Repurchase Program [Member]
Stock Repurchased and Retired During Period, Shares		249,310
Stock Repurchased and Retired During Period, Value		$ 4,360,000
Robert B. Johnston [Member] | Share Repurchase Program [Member]
Stock Repurchased and Retired During Period, Shares	12,000
Stock Repurchased and Retired During Period, Value	$ 210,000

Note 17 - Major Customers (Deta

Note 17 - Major Customers (Details Textual) - Customer Concentration Risk [Member] - Sales Revenue, Net [Member]	12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Distributors for the United States and Canada [Member]
Concentration Risk, Percentage	17.00%	18.00%	17.00%
Former Customer [Member]
Concentration Risk, Percentage	6.00%	10.00%
Another Customer [Member]
Concentration Risk, Percentage	18.00%	7.00%	16.00%

Note 18 - Operations and Indu69

Note 18 - Operations and Industry Segments and Geographic Areas (Details Textual) - USD ($)	12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Number of Reportable Segments	2
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Another Customer [Member]
Concentration Risk, Percentage	18.00%	7.00%	16.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Former Customer [Member]
Concentration Risk, Percentage	6.00%	10.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Medical [Member] | Customer One [Member]
Concentration Risk, Percentage	24.00%	24.00%	22.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Medical [Member] | Another Customer [Member]
Concentration Risk, Percentage	11.00%	11.00%	11.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Custom Products [Member] | Customer One [Member]
Concentration Risk, Percentage	57.00%	29.00%	66.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Custom Products [Member] | Former Customer [Member]
Concentration Risk, Percentage	19.00%	40.00%
Workforce Subject to Collective Bargaining Arrangements [Member] | Unionized Employees Concentration Risk [Member]
Concentration Risk, Percentage	18.00%
CANADA
Net Assets	$ 11,000,000	$ 10,000,000

Note 18 - Operations and Indu70

Note 18 - Operations and Industry Segments and Geographic Areas - Information on Industry Segments (Details) - USD ($)	3 Months Ended								12 Months Ended
	Oct. 01, 2016	Jul. 02, 2016	Apr. 02, 2016	Jan. 02, 2016	Oct. 03, 2015	Jul. 01, 2015	Mar. 31, 2015	Dec. 29, 2014	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Net sales									$ 67,627,170	$ 64,314,996	$ 55,857,375
Operating profit	$ 1,879,000	$ 1,486,000	$ 1,160,000	$ 1,556,000	$ 1,670,000	$ 1,318,000	$ 925,000	$ 1,344,000	6,082,264	5,257,452	3,610,580
Corporate expense									16,198,912	16,378,531	15,179,058
Other income (expense)									(7,933)	407,946	18,187
Income before income taxes									6,074,331	5,665,398	3,628,767
Identifiable assets	33,561,539				32,181,622				33,561,539	32,181,622	35,846,834
Depreciation and Amortization, Operating									1,180,032	1,221,778	1,288,525
Property and equipment, net	4,116,070				4,536,104				4,116,070	4,536,104	4,888,096
Goodwill	3,937,676				3,930,282				3,937,676	3,930,282	4,291,843
Intangibles, net	1,989,899				2,214,762				1,989,899	2,214,762	2,860,260
UNITED STATES
Net sales									60,850,466	56,470,245	49,804,659
Property and equipment, net	3,541,623				3,927,018				3,541,623	3,927,018	4,181,361
Goodwill	1,924,131				1,924,131				1,924,131	1,924,131	1,924,131
Intangibles, net	308,710				309,164				308,710	309,164	303,456
CANADA
Net sales									5,798,244	7,704,410	5,922,543
Property and equipment, net	574,447				609,086				574,447	609,086	706,735
Intangibles, net	1,681,189				1,905,598				1,681,189	1,905,598	2,556,804
Other Areas [Member]
Net sales									978,460	140,341	130,173
Goodwill	2,013,545				2,006,151				2,013,545	2,006,151	2,367,712
Operating Segments [Member]
Net sales									67,627,170	64,314,996	55,857,375
Operating profit									6,841,750	6,107,305	4,224,602
Corporate, Non-Segment [Member]
Corporate expense									(759,486)	(849,853)	(614,022)
Identifiable assets	6,917,614				4,122,862				6,917,614	4,122,862	9,633,841
Depreciation and Amortization, Operating									655	514	409
Capital Expenditures									439,693	654,865	670,845
Medical [Member] | Operating Segments [Member]
Net sales									46,345,525	47,810,988	42,334,896
Operating profit									6,040,202	6,342,253	3,966,605
Identifiable assets	22,299,011				20,886,470				22,299,011	20,886,470	22,221,526
Depreciation and Amortization, Operating									909,972	977,922	1,069,882
Capital Expenditures									322,310	428,206	595,002
Custom Products [Member] | Operating Segments [Member]
Net sales									21,281,645	16,504,008	13,522,479
Operating profit									801,548	(234,948)	257,997
Identifiable assets	$ 4,344,914				$ 7,172,290				4,344,914	7,172,290	3,991,467
Depreciation and Amortization, Operating									269,405	243,342	218,234
Capital Expenditures									$ 117,383	$ 226,659	$ 75,843

Note 19 - Operating Leases (Det

Note 19 - Operating Leases (Details Textual)	12 Months Ended
	Oct. 01, 2016USD ($)	Oct. 03, 2015USD ($)	Sep. 27, 2014USD ($)	Oct. 01, 2016CADft²
Operating Leases, Rent Expense | $	$ 404,000	$ 373,000	$ 375,000
Utah Facility Lease Arrangement [Member]
Area of Real Estate Property | ft²				15,000
Operating Leases, Monthly Rent Payments | $	$ 7,500
Manufacturing and Showroom Facility Lease Arrangement [Member]
Area of Real Estate Property | ft²				50,000
Lessee Leasing Arrangements, Operating Leases, Term of Contract	5 years
Operating Leases, Annual Future Minimum Payments, Due in First and Two Years | CAD				CAD 278,000
Operating Leases, Annual Future Minimum Payments, Due in Fifth Years | CAD				CAD 295,000

Note 20 - Commitments and Con72

Note 20 - Commitments and Contingencies (Details Textual) - USD ($)	12 Months Ended
	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Purchase Obligation, Due in Next Twelve Months	$ 700,000
Unrecorded Unconditional Purchase Obligation, Purchases	829,000	$ 823,000	$ 898,000
License Fees	$ 30,000

Note 21 - Quarterly Financial73

Note 21 - Quarterly Financial Data (Unaudited) - Quarterly Financial Data (Unaudited) (Details) - USD ($)	3 Months Ended								12 Months Ended
	Oct. 01, 2016	Jul. 02, 2016	Apr. 02, 2016	Jan. 02, 2016	Oct. 03, 2015	Jul. 01, 2015	Mar. 31, 2015	Dec. 29, 2014	Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Net sales	$ 15,975,000	$ 15,347,000	$ 14,853,000	$ 21,452,000	$ 17,747,000	$ 15,813,000	$ 15,034,000	$ 15,721,000	$ 67,627,170	$ 64,314,996	$ 55,857,375
Gross profit	5,953,000	5,654,000	5,191,000	5,483,000	5,765,000	5,441,000	4,982,000	5,449,000	22,281,176	21,635,983	18,789,638
Operating income	1,879,000	1,486,000	1,160,000	1,556,000	1,670,000	1,318,000	925,000	1,344,000	6,082,264	5,257,452	3,610,580
Net income	$ 1,412,000	$ 935,000	$ 758,000	$ 1,143,000	$ 1,287,000	$ 963,000	$ 773,000	$ 970,000	$ 4,247,331	$ 3,993,398	$ 2,590,767
Basic (in dollars per share)	$ 0.51	$ 0.34	$ 0.28	$ 0.42	$ 0.43	$ 0.32	$ 0.26	$ 0.33	$ 1.55	$ 1.34	$ 0.88
Diluted (in dollars per share)	$ 0.51	$ 0.34	$ 0.28	$ 0.42	$ 0.43	$ 0.32	$ 0.26	$ 0.32	$ 1.54	$ 1.33	$ 0.87

Schedule VIII Valuation and Q74

Schedule VIII Valuation and Qualifying Accounts - Valuation and Qualifying Accounts (Details) - USD ($)		12 Months Ended
		Oct. 01, 2016	Oct. 03, 2015	Sep. 27, 2014
Allowance for Doubtful Accounts [Member]
Balance at beginning of period		$ 148,000	$ 302,000	$ 263,000
Charged to costs and expenses		(9,007)	38,776	128,925
Deductions-describe	[1]		192,776	89,925
Adjustments		1,007
Balance at end of period		140,000	148,000	302,000
Inventory Valuation Reserve [Member]
Balance at beginning of period		570,000	497,000	720,000
Charged to costs and expenses		22,200	73,000	90,803
Deductions-describe	[2]	35,200		313,803
Adjustments		(32,000)
Balance at end of period		$ 525,000	$ 570,000	$ 497,000
[1]	Uncollectible accounts written off
[2]	Inventory disposed of